Candida glabrata intra-abdominal candidiasis is characterized by persistence within the peritoneal cavity and abscesses

Infection and Immunity

Volumn 82, Issue 7, 2014, Pages 3015-3022

  Cheng, Shaoji ^a   Clancy, Cornelius J ^a,b   Hartman, Douglas J ^a   Hao, Binghua ^a   Hong Nguyen, M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOPHOSPHOLIPASE;

ABDOMINAL ABSCESS; ABDOMINAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; COLONY FORMING UNIT; CONTROLLED STUDY; FECES; FUNGAL STRAIN; HUMAN; HUMAN CELL; IN VITRO STUDY; INOCULATION; INTRAABDOMINAL CANDIDIASIS; INVASIVE CANDIDIASIS; MORTALITY; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PERITONEAL CAVITY; PERITONEAL DISEASE; PERITONEAL FLUID; PERITONITIS; PRIORITY JOURNAL;

ABDOMINAL ABSCESS; ANIMALS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; FECES; GENOTYPE; INTRAABDOMINAL INFECTIONS; MICE; PERITONEAL CAVITY; VIRULENCE;

EID: 84903214575     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00062-14     Document Type: Article

References (32)

1. Blot SI, Vandewoude KH, De Waele JJ. 2007. Candida peritonitis. Curr. Opin. Crit. Care 13:195-199. http://dx.doi.org/10.1097/MCC.0b013e328028fd92.
2. Carneiro HA, Mavrakis A, Mylonakis E. 2011. Candida peritonitis: an update on the latest research and treatments. World J. Surg. 35:2650-2659. http://dx.doi.org/10.1007/s00268-011-1305-2.
3. Nguyen M, Clancy C. 2012. Intra-abdominal candidiasis (IAC) is underrecognized, but is the most common type of invasive candidiasis (IC) and results in poor outcomes, abstr M-1685. 52nd Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
4. Pappas PG. 2006. Invasive candidiasis. Infect. Dis. Clin. North Am. 20: 485-506. http://dx.doi.org/10.1016/j.idc.2006.07.004.
5. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. 1997. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis. 24:1122-1128. http://dx.doi.org/10.1086/513663.
6. phox-/- knockout mice. Antimicrob. Agents Chemother. 46: 1240-1245. http://dx.doi.org/10.1128/AAC.46.5.1240-1245.2002.
7. Mariné M, Espada R, Torrado J, Pastor FJ, Guarro J. 2008. Efficacy of a new formulation of amphotericin B in a murine model of disseminated infection by Candida glabrata. J. Antimicrob. Chemother. 61:880-883. http://dx.doi.org/10.1093/jac/dkn028.
8. Tsoni SV, Kerrigan AM, Marakalala MJ, Srinivasan N, Duffield M, Taylor PR, Botto M, Steele C, Brown GD. 2009. Complement C3 plays an essential role in the control of opportunistic fungal infections. Infect. Immun. 77:3679-3685. http://dx.doi.org/10.1128/IAI.00233-09.
9. Jacobsen ID, Brunke S, Seider K, Schwarzmüller T, Firon A, d'Enfért C, Kuchler K, Hube B. 2010. Candida glabrata persistence in mice does not depend on host immunosuppression and is unaffected by fungal amino acid auxotrophy. Infect. Immun. 78:1066-1077. http://dx.doi.org/10.1128/IAI.01244-09.
10. Brieland J, Essig D, Jackson C, Frank D, Loebenberg D, Menzel F, Arnold B, DiDomenico B, Hare R. 2001. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect. Immun. 69:5046-5055. http://dx.doi.org/10.1128/IAI.69.8.5046-5055.2001.
11. Vonk AG, Netea MG, van Krieken JH, van der Meer JW, Kullberg BJ. 2002. Delayed clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-alpha-and lymphotoxin-alphadeficient mice. J. Infect. Dis. 186:1815-1822. http://dx.doi.org/10.1086/345818.
12. Cheng S, Clancy CJ, Xu W, Schneider F, Hao B, Mitchell AP, Nguyen MH. 2013. Profiling of Candida albicans gene expression during intraabdominal candidiasis identifies biologic processes involved in pathogenesis. J. Infect. Dis. 208:1529-1537. http://dx.doi.org/10.1093/infdis/jit335.
13. Gillum AM, Tsay EY, Kirsch DR. 1984. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198:179-182. http://dx.doi.org/10.1007/BF00328721.
14. Fidel PL, Jr, Cutright JL, Tait L, Sobel JD. 1996. A murine model of Candida glabrata vaginitis. J. Infect. Dis. 173:425-431. http://dx.doi.org/10.1093/infdis/173.2.425.
15. Reuss O, Vik A, Kolter R, Morschhauser J. 2004. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341:119-127. http://dx.doi.org/10.1016/j.gene.2004.06.021.
16. Caudle KE, Barker KS, Wiederhold NP, Xu L, Homayouni R, Rogers PD. 2011. Genomewide expression profile analysis of the Candida glabrata Pdr1 regulon. Eukaryot. Cell 10:373-383. http://dx.doi.org/10.1128/EC.00073-10.
17. Ferrari S, Ischer F, Calabrese D, Posteraro B, Sanguinetti M, Fadda G, Rohde B, Bauser C, Bader O, Sanglard D. 2009. Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog. 5:e1000268. http://dx.doi.org/10.1371/journal.ppat.1000268.
18. Roilides E, Paschalides P, Freifeld A, Pizzo PA. 1993. Suppression of polymorphonuclear leukocyte bactericidal activity by suramin. Antimicrob. Agents Chemother. 37:495-500. http://dx.doi.org/10.1128/AAC.37.3.495.
19. Ghannoum MA. 2000. Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev. 13:122-143, table of contents. http://dx.doi.org/10.1128/CMR.13.1.122-143.2000.
20. Leidich SD, Ibrahim AS, Fu Y, Koul A, Jessup C, Vitullo J, Fonzi W, Mirbod F, Nakashima S, Nozawa Y, Ghannoum MA. 1998. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J. Biol. Chem. 273:26078-26086. http://dx.doi.org/10.1074/jbc.273.40.26078.
21. Casadevall A, Pirofski LA. 2003. The damage-response framework of microbial pathogenesis. Nat. Rev. Microbiol. 1:17-24. http://dx.doi.org/10.1038/nrmicro732.
22. Baker CC, Chaudry IH, Gaines HO, Baue AE. 1983. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94:331-335.
23. Seider K, Brunke S, Schild L, Jablonowski N, Wilson D, Majer O, Barz D, Haas A, Kuchler K, Schaller M, Hube B. 2011. The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation. J. Immunol. 187:3072-3086. http://dx.doi.org/10.4049/jimmunol.1003730.
24. Roetzer A, Klopf E, Gratz N, Marcet-Houben M, Hiller E, Rupp S, Gabaldón T, Kovarik P, Schüller C. 2011. Regulation of Candida glabrata oxidative stress resistance is adapted to host environment. FEBS Lett. 585: 319-327. http://dx.doi.org/10.1016/j.febslet.2010.12.006.
25. Otto V, Howard DH. 1976. Further studies on the intracellular behavior of Torulopsis glabrata. Infect. Immun. 14:433-438.
26. Kaur R, Ma B, Cormack BP. 2007. A family of glycosylphosphatidylinositol-linked aspartyl proteases is required for virulence of Candida glabrata. Proc. Natl. Acad. Sci. U. S. A. 104:7628-7633. http://dx.doi.org/10.1073/pnas.0611195104.
27. Finlay-Jones JJ, Davies KV, Sturm LP, Kenny PA, Hart PH. 1999. Inflammatory processes in a murine model of intra-abdominal abscess formation. J. Leukoc. Biol. 66:583-587.
28. Finlay-Jones JJ, Kenny PA, Nulsen MF, Spencer LK, Hill NL, McDonald PJ. 1991. Pathogenesis of intraabdominal abscess formation: abscesspotentiating agents and inhibition of complement-dependent opsonization of abscess-inducing bacteria. J. Infect. Dis. 164:1173-1179. http://dx.doi.org/10.1093/infdis/164.6.1173.
29. Giuliano M, Barza M, Jacobus NV, Gorbach SL. 1987. Effect of broadspectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob. Agents Chemother. 31:202-206. http://dx.doi.org/10.1128/AAC.31.2.202.
30. Krause R, Krejs GJ, Wenisch C, Reisinger EC. 2003. Elevated fecal Candida counts in patients with antibiotic-associated diarrhea: role of soluble fecal substances. Clin. Diagn. Lab. Immunol. 10:167-168. http://dx.doi.org/10.1128/CDLI.10.1.167-168.2003.
31. Arendrup M, Horn T, Frimodt-Moller N. 2002. In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection 30:286-291. http://dx.doi.org/10.1007/s15010-002-2131-0.
32. De Las Peñas A, Pan SJ, Castano I, Alder J, Cregg R, Cormack BP. 2003. Virulence-related surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric clusters and subject to RAP1-and SIR-dependent transcriptional silencing. Genes Dev. 17:2245-2258. http://dx.doi.org/10.1101/gad.1121003.